T1	Drug 20 31	sitagliptin
T2	Drug 35 44	metformin
T3	Drug 48 65	thiazolidinedione
*	OR T2 T3 T1
T4	Condition 0 16	Contraindication
T5	Scope 20 65	sitagliptin or metformin or thiazolidinedione
R1	Has_scope Arg1:T4 Arg2:T5	
T6	Condition 67 75	Pregnant
T7	Condition 79 85	breast
*	OR T7 T6
T8	Condition 101 116	Type 1 diabetes
T9	Condition 118 138	gestational diabetes
T10	Condition 143 170	secondary forms of diabetes
*	OR T9 T10 T8
T11	Negation 172 175	Not
T12	Observation 176 187	appropriate
T13	Drug 192 215	oral antidiabetic agent
R2	AND Arg1:T12 Arg2:T13	
R3	Has_negation Arg1:T12 Arg2:T11	
T14	Drug 217 227	Medication
T15	Observation 234 257	affect glycemic control
R4	AND Arg1:T15 Arg2:T14	
T16	Drug 259 266	Disease
T17	Qualifier 273 288	affect efficacy
T18	Qualifier 293 308	safety of drugs
*	OR T17 T18
T19	Scope 273 308	affect efficacy and safety of drugs
R5	Has_scope Arg1:T16 Arg2:T19	
T20	Condition 314 327	major illness
T21	Condition 329 342	Liver disease
T22	Condition 344 357	Renal failure
T23	Condition 359 372	Heart disease
T24	Condition 374 380	Cancer
*	OR T24 T23 T22 T21
T25	Scope 329 380	Liver disease, Renal failure, Heart disease, Cancer
R6	Subsumes Arg1:T20 Arg2:T25	
